Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Critical review: vegetables and fruit in the prevention of chronic diseases
2012 Standout
Angiotensin II receptor antagonists in heart failure: Rationale and design of the evaluation of losartan in the elderly (ELITE) trial
1995
Cardiovascular prevention and blood pressure reduction
2003
Atherosclerotic Renal Artery Stenosis
2002 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure
2004 StandoutNobel
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature
2009
Epidemiology of COPD
2009 Standout
A global view of pulmonary hypertension
2016 Standout
Chymase-dependent angiotensin II forming system in humans
1996
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Endurance exercise performance: the physiology of champions
2007 Standout
Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France
2017 Standout
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
The Pleiotropic Effects of Angiotensin Receptor Blockers
2006
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Stability of antineoplastic agents in use for home-based intravenous chemotherapy
2008
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure
1996
Analysis of anticancer drugs: A review
2011 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise
1999
Forebrain Pathways Mediating Stress-Induced Hormone Secretion
1999
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
2009 Standout
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
2001 Standout
ACTN3 Genotype Is Associated with Human Elite Athletic Performance
2003 Standout
Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure
2000
The French CONSTANCES population-based cohort: design, inclusion and follow-up
2015
Blood Pressure Reduction and Cardiovascular Prevention: An Update Including the 2003-2004 Secondary Prevention Trials
2005
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
2000 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure
1998 Standout
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
2000 Standout
?Escape? of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy
1995
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status
2000
Improvement in Exercise Tolerance and Symptoms of Congestive Heart Failure During Treatment With Candesartan Cilexetil
1999
Works of F. Dalmay being referenced
Angiotensin-Converting Enzyme Inhibition Does Not Suppress Plasma Angiotensin II Increase During Exercise in Humans
1993
Analyse économique de l’administration d’une chimiothérapie en hospitalisation à domicile (HAD) comparée à l’hospitalisation de jour dans les cancers bronchopulmonaires non à petites cellules de stade IV
2006
FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: Do prediction equations need revision?
2008
Impact of chronic airflow obstruction in a working population
2008
Non-AT1-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil
2001